With a number of COVID-19 vaccines now approved, the debate has shifted to the logistical challenges of transporting vaccines across an unbroken and continuous cold chain.
When it comes to pursuing supply-chain sustainability and social responsibility, has the pandemic caused companies to take their eye off the ball? Read more.
The Federal Reserve is seeing a lot more shortages across the U.S. economy, in ways that might be construed as early warning signs of inflation if they persist.
Jay Johnson, senior manager of Labelmaster Services, explains why regulations on the handling of hazardous materials apply to distributors of the COVID-19 vaccine, even though the vaccine isn’t itself classified as a “dangerous good” for purposes of transportation.
Lipids catapulted toward the top of the world’s health-care priority list because the COVID-19 vaccines from Pfizer, Moderna and others can’t do their job without them.
U.K. Chancellor Rishi Sunak unveiled a roster of eight English freeports, low-tariff business zones being created to stimulate trade and investment in the wake of Brexit and the coronavirus crisis.